Zimmer Biomet Holdings Faces Valuation Concerns Amid Share Price Decline

Zimmer Biomet Holdings (ZBH) shares have declined 4.27% in the last 30 days, with a 1-year total shareholder return of 19.27%. The stock is currently undervalued by 48% and has a fair value of $102.39. The company's investment in digital health, robotics, and data-driven surgical solutions is driving adoption of premium offerings and recurring revenues. However, competitive pressure in robotics and potential acquisition disappointments pose risks to the narrative.